Richard B. Smith focuses his practice on representation of life sciences companies and related transactions. He has served as counsel to public, private and emerging life sciences companies, advising those companies on strategic business transactions such as licensing, joint ventures, and collaborations involving research, development, marketing, supply, clinical development and co-promotion of pharmaceutical, diagnostic and medical device products.
Richard also advises companies on other corporate issues common to life sciences companies, including corporate formation of new ventures, venture capital, private equity, venture philanthropy and other forms of financing, mergers and acquisitions, as well as university and institutional licensing and intellectual property strategies.
Education
Suffolk University Law School, JD
Rensselaer Polytechnic Institute, ME
Rensselaer Polytechnic Institute, BS
Admissions
Massachusetts
Courts / Agencies
US Patent and Trademark Office
Cambridge, MA / McDermott Event / March 20, 2019
San Francisco, CA / Speaking Engagements / January 8, 2019
Banker & Tradesman / November 27, 2016
The M&A Lawyer / June 2014
"Commercially Reasonable Efforts" Diligence Obligations in Life Science M&A
1
Law 360 / November 20, 2018
Press Releases / October 26, 2018
McDermott Advises Innate Pharma in Expanding its Collaboration with AstraZeneca
Paris / Press Releases / December 3, 2015
McDermott Advises Servier on Strategic Agreement with Cellectis
Le Monde du Droit (France) / November 25, 2015
Frankfurt / Press Releases / 16. November 2015
Börsengang der Curetis N.V. an der Euronext in Amsterdam und ...
Paris / Press Releases / November 21, 2014
McDermott Advises Servier in its Strategic Partnership with Intarcia Therapeutics Valued at ...
Law in France (France) / November 13, 2014
Press Releases / July 2, 2014
1
2
Do not send any information or documents that you want to have treated as secret or confidential. Providing information to McDermott via email links on this website or other introductory email communications will not create an attorney-client relationship; will not preclude McDermott from representing any other person or firm in any matter; and will not obligate McDermott to keep confidential the information you provide. McDermott cannot enter into an attorney-client relationship with you until McDermott has determined that doing so will not create a conflict of interest and until you and McDermott have entered into a written agreement or engagement letter that sets forth the terms of our relationship.
We use cookies to improve the functionality and performance of this site. By continuing to use this site, you are providing us with your consent to our use of cookies. Please see our Privacy Policy for details.